Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours

NCT02992912 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )

Interventions

DRUG: Anti-PD-L1 antibody atezolizumab
PROCEDURE: SABR

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris